Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-02-16 Sale | 2024-02-20 6:36 pm | Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO AND SECRETARY | 2,666 | $15.25 | $40,651 | 411,504 (Direct) | View |
| 2023-11-16 Sale | 2023-11-17 6:33 pm | Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO and Secretary | 956 | $11.69 | $11,176 | 308,170 (Direct) | View |
| 2023-08-17 Sale | 2023-08-17 7:02 pm | Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO and Secretary | 922 | $13.86 | $12,779 | 309,126 (Direct) | View |
| 2023-05-16 Sale | 2023-05-17 6:36 pm | Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO and Secretary | 955 | $13.12 | $12,532 | 310,048 (Direct) | View |
| 2023-02-17 Sale | 2023-02-21 5:01 pm | Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO and Secretary | 9,377 | $20.03 | $187,790 | 262,128 (Direct) | View |
| 2023-02-16 Sale | 2023-02-17 5:35 pm | Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO and Secretary | 930 | $19.57 | $18,203 | 320,380 (Direct) | View |
| 2023-01-20 Sale | 2023-01-23 6:00 pm | Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO and Secretary | 10,000 | $22.75 | $227,523 | 268,810 (Direct) | View |
| 2022-12-20 Sale | 2022-12-22 5:43 pm | Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO and Secretary | 10,000 | $20.07 | $200,650 | 276,497 (Direct) | View |
| 2022-11-21 Sale | 2022-11-22 6:46 pm | Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO and Secretary | 10,000 | $20.76 | $207,570 | 286,497 (Direct) | View |
| 2022-11-16 Sale | 2022-11-17 5:49 pm | Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO and Secretary | 430 | $21.46 | $9,228 | 312,997 (Direct) | View |
| 2022-11-01 Sale | 2022-11-03 5:49 pm | Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO and Secretary | 10,000 | $20.03 | $200,313 | 294,401 (Direct) | View |
| 2022-10-03 Sale | 2022-10-05 4:36 pm | Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO and Secretary | 10,000 | $20.05 | $200,473 | 304,401 (Direct) | View |
| 2022-09-01 Sale | 2022-09-06 7:54 pm | Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO and Secretary | 10,000 | $23.25 | $232,484 | 314,401 (Direct) | View |
| 2022-08-16 Sale | 2022-08-17 7:23 pm | Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO and Secretary | 1,089 | $24.31 | $26,474 | 342,276 (Direct) | View |
| 2022-08-04 Sale | 2022-08-05 5:20 pm | Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO and Secretary | 10,000 | $20.05 | $200,541 | 321,365 (Direct) | View |
| 2022-07-18 Sale | 2022-07-20 6:18 pm | Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO and Secretary | 2,500 | $20 | $50,000 | 331,365 (Direct) | View |
| 2022-07-08 Sale | 2022-07-12 7:31 pm | Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO and Secretary | 1,416 | $20 | $28,320 | 333,865 (Direct) | View |
| 2022-07-01 Sale | 2022-07-06 9:00 pm | Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO and Secretary | 2,279 | $20 | $45,580 | 335,281 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-15 Exercise | 2024-02-20 6:36 pm | N/A N/A | Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO AND SECRETARY | 10,250 | $0 | 411,504 (Direct) | View |
| 2024-01-05 Option Award | 2024-01-09 7:29 pm | N/A 2034-01-04 | Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO and Secretary | 268,000 | $0 | 268,000 (Direct) | View |
| 2023-11-15 Exercise | 2023-11-17 6:33 pm | N/A N/A | Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO and Secretary | 3,625 | $0 | 308,170 (Direct) | View |
| 2023-08-15 Exercise | 2023-08-17 7:02 pm | N/A N/A | Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO and Secretary | 3,625 | $0 | 309,126 (Direct) | View |
| 2023-05-15 Exercise | 2023-05-17 6:36 pm | N/A N/A | Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO and Secretary | 3,625 | $0 | 310,048 (Direct) | View |
| 2023-02-15 Exercise | 2023-02-17 5:35 pm | N/A N/A | Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO and Secretary | 3,625 | $0 | 320,380 (Direct) | View |
| 2023-01-17 Option Award | 2023-01-19 5:02 pm | N/A 2033-01-16 | Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO and Secretary | 152,000 | $0 | 152,000 (Direct) | View |
| 2022-11-15 Exercise | 2022-11-17 5:49 pm | N/A N/A | Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO and Secretary | 1,375 | $0 | 312,997 (Direct) | View |
| 2022-08-15 Exercise | 2022-08-17 7:23 pm | N/A 2032-01-17 | Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO and Secretary | 4,125 | $0 | 342,276 (Direct) | View |
| 2022-01-18 Option Award | 2022-01-20 7:30 pm | N/A 2032-01-17 | Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO and Secretary | 173,000 | $0 | 173,000 (Direct) | View |
Ownership | 2021-05-26 8:58 pm | N/A N/A | Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO and Secretary | 0 | $0 | 835,227 (Direct) | View |
| 2020-02-14 Option Award | 2020-02-19 5:15 pm | N/A 2030-02-13 | Aeglea BioTherapeutics Inc. | AGLE | York Charles N II Chief Financial Officer and VP | 126,000 | $0 | 126,000 (Direct) | View |